Showing results (51-60 of 77) with videos related to
Sort By:
Pageof 8
Biomed Research International|July 11, 2013
Urine bikunin as a marker of renal impairment in Fabry's diseaseAntonio Junior Lepedda, Laura Fancellu, Elisabetta Zinellu, et al.Molecules (Basel, Switzerland)|April 3, 2021
Delivery of Thyronamines (TAMs) to the Brain: A Preliminary StudyNicoletta di Leo, Stefania Moscato, Marco Borso', et al.Frontiers in Pharmacology|January 10, 2018
New Insights into the Potential Roles of 3-Iodothyronamine (T1AM) and Newly Developed Thyronamine-Like TAAR1 Agonists in NeuroprotectionLorenza Bellusci, Annunziatina Laurino, Martina Sabatini, et al.Orphanet Journal of Rare Diseases|June 29, 2022
Cardiac involvement in MPS patients: incidence and response to therapy in an Italian multicentre studySimona Sestito, Giada Rinninella, Angelica Rampazzo, et al.Journal of Experimental & Clinical Cancer Research : CR|May 16, 2019
Preclinical validation of 3-phosphoinositide-dependent protein kinase 1 inhibition in pancreatic cancerAikaterini Emmanouilidi, Chanse A Fyffe, Riccardo Ferro, et al.Pharmaceuticals (Basel, Switzerland)|March 29, 2023
Design, Synthesis, and Antiviral Activities of New Benzotriazole-Based DerivativesRoberta Ibba, Paola Corona, Francesca Nonne, et al.European Journal of Medicinal Chemistry|July 9, 2024
Discovery of pyridoquinoxaline-based new P-gp inhibitors as coadjutant against Multi Drug Resistance in cancerRoberta Ibba, Simona Sestito, Francesca Alessandra Ambrosio, et al.European Journal of Medicinal Chemistry|January 14, 2020
Design, synthesis and biological evaluation of novel TRβ selective agonists sustained by ADME-toxicity analysisMassimiliano Runfola, Simona Sestito, Lorenza Bellusci, et al.European Journal of Medicinal Chemistry|October 8, 2021
Development of potent dual PDK1/AurA kinase inhibitors for cancer therapy: Lead-optimization, structural insights, and ADME-Tox profileSimona Sestito, Andrea Bacci, Sara Chiarugi, et al.Journal of Clinical Medicine|March 28, 2026
Pattern of Oculomotor Findings in Children with Attention Deficit/Hyperactivity Disorder in Relation to Methylphenidate TreatmentClaudia Brogna, Valentina Napoli, Laura Castellini, et al.Pageof 8